Persist AI raises $12M in Series A funding to launch its Cloud Lab for accelerating pharmaceutical formulation development, led by Spero Ventures.

May 19, 2025•3 months ago

Amount Raised

$12 Million

West SacramentoHealth Care

Investors

Y CombinatorInnospark2048 VenturesAsymmetry VenturesCartography CapitalGood Ai CapitalPurdue VenturesFord Street CapitalSignal FireEli Lilly & CompanyShimadzu Future Innovation Fund Managed By Global Brain CorporationMbx CapitalSpero Ventures

Description

Persist AI announced the launch of its Cloud Lab platform after raising $12 million in an oversubscribed Series A financing round. The platform enables pharmaceutical companies to accelerate drug formulation development using advanced robotics. This funding round was led by Spero Ventures, alongside multiple other investors. The investment aims to lower the hurdles in developing next-generation therapeutics.

Company Information

Company

Persist AI

Location

890 Embarcadero Dr.

West Sacramento, California, United States

About

Persist AI is revolutionizing pharmaceutical development through AI-driven robotics for formulation development and CMC. By combining predictive AI models with automated robotic systems, Persist AI enables pharmaceutical companies to develop drug formulations in a fraction of the time and cost of traditional approaches. The company works across multiple modalities and formulation types to accelerate bringing novel therapeutics to patients. Persist AI is a Y Combinator-backed company, having graduated from the prestigious startup accelerator in 2023.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech